Treatment of refractory acute myelogenous leukemia (AML) with vincristine, high dose methotrexate, 1,3-bis-(2-chlorethyl)-1-nitrosourea (BCNU), cyclophosphamide, and methyl-glyoxal bis-guanylhydrazone (MGBG)

T. S. Herman, B. G.M. Durie, J. Hutter

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)C-559
JournalProceedings of the American Association for Cancer Research
VolumeVol. 22
StatePublished - 1981
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this